Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Prospective follow-up of the Prevision hip stem with comparison of implant variants

Official title: Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants

Run by Aesculap AG · NCT06626490 · Data updated 2026-11-12

This project will test whether adults receiving the Prevision revision hip stem have similar two-year hip function and safety as those who received the previous implant generation or comparable revision stems.

More Total Hip Arthroplasty (THA) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorAesculap AG
Industry-sponsored
Locations2 sites (Hanover and 1 other locations)
StatusRecruiting
StartedApril 7, 2026
Main results expectedMarch 2033
Study endsMarch 2034
Registry record updatedNovember 9, 2026
Trial IDNCT06626490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing revision total hip arthroplasty who receive a Prevision revision stem, can give written informed consent, and are able to attend follow‑up visits are eligible.

Probably not a fit

Patients under 18, those who are pregnant, held in custody, in a dependent relationship with the sponsor/clinic/investigator, or unable to attend follow‑up visits are not expected to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational post‑market follow-up of patients treated with the Prevision revision hip stem, designed as a non‑inferiority comparison of two‑year functional outcomes measured by the Oxford Hip Score (OHS) against the predecessor implant generation and comparable revision stems. Study sites choose which Prevision variant to implant according to routine practice, with all variants available and switching between variants encouraged. The primary focus is patient‑reported function at two years, with descriptive comparisons of subgroups treated with different stem variants and systematic collection of clinical performance and safety data. No randomized assignment is used; outcomes reflect real‑world use across participating orthopedic centers.

Why it matters

Potential benefit: If successful, the results could confirm that the Prevision family provides comparable two‑year hip function and safety, giving surgeons flexible implant options with consistent patient outcomes.

How similar studies have gone: Modular and variant revision hip stems have been used in clinical practice with generally acceptable outcomes, but this observational follow‑up specifically aims to confirm non‑inferiority for the Prevision family.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Revision hip arthroplasty patients treated with a Prevision hip stem
* Written patient informed consent
* Patients are able to attend at follow-up examinations

Exclusion Criteria:

* Patients \< 18 years at surgery
* Pregnancy at implantation
* Patients held in a custodial setting
* Patients in a relationship of dependence on the sponsor, the clinic or the investigator

Where it's running

  • Orthopädische Kliniken im Annastift, MHH, Anna-von-Borries-Str. 1-7
    Hanover, Germany
    Recruiting
  • Hinchingbrooke Hospital
    Huntingdon, Cambridgeshire, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Henning Windhagen, Prof. Dr. — Orthopädische Kliniken im Annastift, MHH
  • Study coordinator: Kerstin Bergmann
  • Email: studies@aesculap.de
  • Phone: +49746195-

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.